Search Results

Xenco Medical Cervical Interbody System devices are intended for spinal fusion procedures at one level (C3-C7) in skeletally mature patients with degenerative disc disease (defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies) of the cervical spine. Devices are to be implanted via an open, anterior approach and packed with autogenous bone. Patients should have had at least six weeks of non-operative treatment prior to surgical treatment with the device is intended to be used with supplemental fixation (e.g. anterior plate system).

Xenco Medical Lumbar Interbody System devices are intended for spinal fusion procedures at one or two contiguous levels (L2-S1) in skeletally mature patients with degenerative disc disease (DDD). DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. DDD patients may also have up to Gradel spondylolisthesis or retrolisthesis at the involved levels. These patients may have had a previous nonfusion spinal surgery at the involved spinal level(s). The device is intended to be used with supplemental fixation systems that have been cleared for use in the lumbrosacral spine (e.g. posterior pedicle screw and rod systems, anterior plate systems, and anterior screw and rod systems). Hyperlordotic interbody devices (20° lordosis) must be used with at least anterior supplemental fixation. The device is intended to be used with autogenous bone graft. Patients must have undergone a regimen of at least six months of non-operative treatment prior to being treated with the Xenco Medical device.

Not Found

This document is a 510(k) premarket notification decision letter from the FDA for the "Xenco Medical Cervical Interbody System" and "Xenco Medical Lumbar Interbody System." It confirms that the devices are substantially equivalent to legally marketed predicate devices and can be marketed.

However, the provided text does not contain any information regarding acceptance criteria, device performance, study data, sample sizes, ground truth establishment, expert qualifications, or MRMC studies. The document is a regulatory approval letter based on substantial equivalence, not a detailed report of a clinical or performance study.

Therefore, I cannot fulfill your request for a table of acceptance criteria and reported device performance or any other details about studies showing the device meets acceptance criteria, as this information is not present in the provided text. The FDA letter states that the review was based on the 510(k) submission, but the content of that submission, including performance data, is not included here.

Ask a specific question about this device